Article Details

116.28% to Target, Chardan Capital Reiterates Buy Rating for ADMA Biologics (ADMA) Stock ...

Retrieved on: 2019-03-14 05:52:16

Tags for this article:

Click the tags to see associated articles and topics

116.28% to Target, Chardan Capital Reiterates Buy Rating for ADMA Biologics (ADMA) Stock .... View article details on HISWAI:

Excerpt

<div>Gallagher Fiduciary Advisors Llc decreased <b>Finisar</b> Corp. (FNSR) stake by 5.9% reported in 2018Q4 SEC filing. Gallagher Fiduciary Advisors Llc sold ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up